array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(27) "BOOTS INTERNATIONAL LIMITED"
["slug"]=>
string(36) "d6155-gb-boots-international-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/c48869a8-5470-4069-ad6e-886fee8b8d76"
["description"]=>
string(1179) "Boots UK (boots.com), the UK’s largest pharmacy-led health and beauty retailer, is part of the Retail Pharmacy International Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise.
Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail pharmacy, impacting millions of lives every day through dispensing medicines, and providing accessible, high-quality care. With more than 170 years of trusted healthcare heritage and innovation in community pharmacy, the company is
meeting customers’ and patients’ needs through its convenient retail locations, digital platforms and health and beauty products.
With 2,465* stores in the UK, its purpose is to champion everyone’s right to feel good. Boots UK is committed to providing exceptional customer and patient care, be the first choice for pharmacy and healthcare and offer innovative 'only at Boots' exclusive products such as No7, a leading UK skincare brand, Soap and Glory and Liz Earle. Created 170 years ago, the Boots brand is still at the heart of the communities it serves.
*As of August 31, 2019 excluding equity method investments"
["address_street"]=>
string(11) "Po Box 5300"
["address_place"]=>
string(10) "NOTTINGHAM"
["address_region"]=>
NULL
["founding_date"]=>
NULL
["website_domain"]=>
string(10) "boots.jobs"
["website_url"]=>
string(22) "https://www.boots.jobs"
["industry_codes"]=>
array(1) {
[0]=>
string(50) "Drugs, Drug Proprietaries, and Druggists' Sundries"
}
["employee_count"]=>
int(52)
["article_count"]=>
int(89)
}
["articles"]=>
array(2) {
[0]=>
array(7) {
["title_en"]=>
string(138) "Boots UK to consolidate number of stores in close proximity to each other - Latest Pharmacy News | Business | Magazine - Pharmacy Business"
["snippet_en"]=>
string(300) "Boots UK has unveiled its plan while announcing the Q3 result on Tuesday (27 June), to close 300 stores in 'close proximity to each other' over the next year. `` Evolving the store estate in this way allows Boots to concentrate its team members where they are needed and focus investment more acutely"
["url"]=>
string(99) "https://www.pharmacy.biz/boots-uk-to-consolidate-number-of-stores-in-close-proximity-to-each-other/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/913a7307-8832-4dab-8275-c5e1b41fa253"
["source"]=>
string(12) "pharmacy.biz"
["publication_date"]=>
string(10) "2023-06-28"
["categories"]=>
array(6) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(10) "Downsizing"
[2]=>
string(10) "Divestment"
[3]=>
string(18) "Ecological Impacts"
[4]=>
string(18) "General Investment"
[5]=>
string(14) "Product Launch"
}
}
[1]=>
array(7) {
["title_en"]=>
string(12) "Boots (SWOT)"
["snippet_en"]=>
string(232) "Boots’ merger with Walgreens, the largest drugstore operator in the US, provided huge scale and Boots UK has benefited from the group’s technological investment and other synergies. In the UK, Boots is the largest chemist chain."
["url"]=>
string(85) "https://www.retail-week.com/retail-navigator/boots/boots-swot/7038196.supplierarticle"
["image_url"]=>
NULL
["source"]=>
string(15) "retail-week.com"
["publication_date"]=>
string(10) "2021-04-13"
["categories"]=>
array(4) {
[0]=>
string(18) "General Investment"
[1]=>
string(23) "Supply Chain Management"
[2]=>
string(6) "Merger"
[3]=>
string(21) "Competitive Behaviour"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(10) "Downsizing"
["count"]=>
int(6)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(6)
}
[2]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(5)
}
[3]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(5)
}
[4]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(5)
}
[5]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(5)
}
[6]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(4)
}
[9]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(4)
}
[10]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(4)
}
[11]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(3)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(3)
}
[13]=>
array(2) {
["name"]=>
string(21) "Financial Performance"
["count"]=>
int(3)
}
[14]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(3)
}
[15]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(2)
}
[16]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(2)
}
[17]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(2)
}
[18]=>
array(2) {
["name"]=>
string(19) "Government Policies"
["count"]=>
int(2)
}
[19]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(2)
}
[20]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(2)
}
[21]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(2)
}
[22]=>
array(2) {
["name"]=>
string(23) "Real estate development"
["count"]=>
int(2)
}
[23]=>
array(2) {
["name"]=>
string(22) "Business Restructuring"
["count"]=>
int(2)
}
[24]=>
array(2) {
["name"]=>
string(14) "Reorganisation"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(16) "Safety Disregard"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(12) "Slash Prices"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(1)
}
[28]=>
array(2) {
["name"]=>
string(25) "Start-up's & New Business"
["count"]=>
int(1)
}
[29]=>
array(2) {
["name"]=>
string(6) "Strike"
["count"]=>
int(1)
}
}
}
d6155-gb-boots-international-limited
BOOTS INTERNATIONAL LIMITED
Location
Founded
Website
https://www.boots.jobs
Articles
89 Articles
Category
Drugs, Drug Proprietaries, and Druggists' Sundries
Description
Boots UK (boots.com), the UK’s largest pharmacy-led health and beauty retailer, is part of the Retail Pharmacy International Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise.
Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail pharmacy, impacting millions of lives every day through dispensing medicines, and providing accessible, high-quality care. With more than 170 years of trusted healthcare heritage and innovation in community pharmacy, the company is
meeting customers’ and patients’ needs through its convenient retail locations, digital platforms and health and beauty products.
With 2,465* stores in the UK, its purpose is to champion everyone’s right to feel good. Boots UK is committed to providing exceptional customer and patient care, be the first choice for pharmacy and healthcare and offer innovative 'only at Boots' exclusive products such as No7, a leading UK skincare brand, Soap and Glory and Liz Earle. Created 170 years ago, the Boots brand is still at the heart of the communities it serves.
*As of August 31, 2019 excluding equity method investments
Boots UK has unveiled its plan while announcing the Q3 result on Tuesday (27 June), to close 300 stores in 'close proximity to each other' over the next year. `` Evolving the store estate in this way allows Boots to concentrate its team members where they are needed and focus investment more acutely
Boots’ merger with Walgreens, the largest drugstore operator in the US, provided huge scale and Boots UK has benefited from the group’s technological investment and other synergies. In the UK, Boots is the largest chemist chain.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.